Halozyme Therapeutics, Inc.

SCHRODER INVESTMENT MANAGEMENT GROUP HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

137,139

Value ($000)

9,284

Weight

0.0%

2020 Q3 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	9,284	0.0%	137,139	12/31/2025
2025 Q2	8/13/2025	12,848	0.0%	246,975	6/30/2025
2025 Q1	5/13/2025	15,482	0.0%	242,507	3/31/2025
2024 Q4	2/12/2025	4,199	0.0%	87,503	12/31/2024
2024 Q3	11/13/2024	8,337	0.0%	146,339	9/30/2024
2024 Q2	8/12/2024	763	0.0%	14,580	6/30/2024
2024 Q1	5/14/2024	6,736	0.0%	165,579	3/31/2024
2023 Q4	2/14/2024	2,299	0.0%	62,200	12/31/2023
2023 Q2	8/11/2023	648	0.0%	17,952	6/30/2023
2023 Q1	5/11/2023	20,426	0.0%	534,860	3/31/2023
2022 Q4	2/10/2023	5,850	0.0%	102,817	12/31/2022
2022 Q3	11/14/2022	1,629	0.0%	41,197	9/30/2022
2021 Q3	11/12/2021	3,321	0.0%	81,637	9/30/2021
2021 Q2	8/13/2021	29,637	0.0%	652,658	6/30/2021
2021 Q1	5/28/2021	23,210	0.0%	556,726	3/31/2021
2020 Q4	2/16/2021	4,839	0.0%	113,297	12/31/2020
2020 Q3	11/13/2020	3,687	0.0%	142,849	9/30/2020